Ligands of Immunopharmacology

Teriflunomide impurity 3 (4-Amino-N-(4-trifluoromethylphenyl)benzamide) is a selective COX-1 inhibitor with an IC 50 of 30 µM. Teriflunomide impurity 3 is less active against COX-2 (IC 50 &gt100 µM)In VitroTeriflunomide impurity 3

Teriflunomide impurity 3 (4-Amino-N-(4-trifluoromethylphenyl)benzamide) is a selective COX-1 inhibitor with an IC 50 of 30 µM. Teriflunomide impurity 3 is less active against COX-2 (IC 50 &gt100 µM)In VitroTeriflunomide impurity 3

Tilmacoxib (JTE522) is a highly selective, time-dependent and irreversible human COX-2 inhibitor with an IC 50 of 85 nM in an enzyme assay.In VitroInhibitory activity and the mechanism of action of Tilmacoxib (JTE-522), a novel selective

TIM-3-IN-1 represents useful tool to further study the biology of TIM-3 immune modulation in cancer .Appearance:SolidBiological Activity:TIM-3-IN-1 represents useful tool to further study the biology of TIM-3 immune modulation in cancer .

TIM-3-IN-1 represents useful tool to further study the biology of TIM-3 immune modulation in cancer .Appearance:SolidBiological Activity:TIM-3-IN-1 represents useful tool to further study the biology of TIM-3 immune modulation in cancer .

TJ-M2010-5 is a MyD88 inhibitor that binds to the TIR domain of MyD88 to interfere with its homodimerization, and the TLR/MyD88 signal pathway. TJ-M2010-5 can be used for the research of myocardial ischemia/reperfusion injury (MIRI) .In

TJ-M2010-5 is a MyD88 inhibitor that binds to the TIR domain of MyD88 to interfere with its homodimerization, and the TLR/MyD88 signal pathway. TJ-M2010-5 can be used for the research of myocardial ischemia/reperfusion injury (MIRI) .In

TJ-M2010-5 is a MyD88 inhibitor that binds to the TIR domain of MyD88 to interfere with its homodimerization, and the TLR/MyD88 signal pathway. TJ-M2010-5 can be used for the research of myocardial ischemia/reperfusion injury (MIRI) .In

TJ-M2010-5 is a MyD88 inhibitor that binds to the TIR domain of MyD88 to interfere with its homodimerization, and the TLR/MyD88 signal pathway. TJ-M2010-5 can be used for the research of myocardial ischemia/reperfusion injury (MIRI) .In

TJ-M2010-5 is a MyD88 inhibitor that binds to the TIR domain of MyD88 to interfere with its homodimerization, and the TLR/MyD88 signal pathway. TJ-M2010-5 can be used for the research of myocardial ischemia/reperfusion injury (MIRI) .In

TL8-506 is a specific TLR8 agonist with an EC 50 of 30 nM. TL8-506 can be used for the research of tuberculosis and autoimmune diseases.Form:Solid

TL8-506 is a specific TLR8 agonist with an EC 50 of 30 nM. TL8-506 can be used for the research of tuberculosis and autoimmune diseases.Form:Solid